GlassScriptPhysician profile
Chansina Um
NPI 1689603466
$3,096.83
in general payments reported to CMS, 2019-2025
37 companies · $593 in 2025
The $593 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $564 · 2020: $314 · 2021: $404 · 2022: $219 · 2023: $303 · 2024: $700 · 2025: $593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,595.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $690.71 | 2019-2025 | Grafix Pl |
| Paratek Pharmaceuticals, INC. | $327.39 | 2021-2025 | Nuzyra |
| Organogenesis INC. | $248.17 | 2021-2025 | Puraply, Affinity |
| Integra Lifesciences Corporation | $186.35 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Depuy Synthes Sales INC. | $168.13 | 2020-2024 | Motoband, Na, Healix Knotless Peek |
| Stryker Corporation | $114.64 | 2023-2025 | Prostep, Citrefix, Flexband |
| Nevro Corp. | $110.42 | 2023-2024 | Senza |
| Kerecis Limited | $104.53 | 2019-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Wound Management Technologies, INC | $96.56 | 2019 | |
| Peerless Surgical INC. | $90.14 | 2020-2025 | |
| Treace Medical Concepts, INC. | $84.56 | 2024-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $79.32 | 2020-2021 | |
| Convatec INC. | $79.07 | 2024-2025 | |
| Sebela Pharmaceuticals INC. | $71.36 | 2020-2023 | Naftin |
| Abbvie INC. | $69.62 | 2021-2024 | Dalvance |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $62.13 | 2023-2025 | Qutenza |
| Sandoz INC. | $59.49 | 2019 | |
| Nabriva Therapeutics, Plc | $38.55 | 2022 | |
| Merck Sharp & Dohme LLC | $36.90 | 2019 | |
| Innovation Technologies INC | $35.71 | 2023-2025 | Irrisept |
| Amgen INC. | $32.77 | 2024 | Krystexxa |
| Polynovo North America LLC | $31.39 | 2023 | |
| Acera Surgical, INC. | $29.44 | 2025 | Restrata Wound Matrix |
| Trice Medical, INC. | $25.69 | 2024 | |
| Cashflow Solutions, LLC | $25.12 | 2022-2024 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Globus Medical, INC. | $23.62 | 2025 | Omnia |
| Misonix INC | $23.45 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $22.00 | 2019 | |
| Grt US Holding, INC. | $21.95 | 2021 | |
| Horizon Therapeutics Plc | $21.52 | 2020 | |
| Medtronic, INC. | $15.47 | 2023 | Intellis Adaptivestim |
| Prugen, INC. Pharmaceuticals | $15.39 | 2019 | |
| Osiris Therapeutics INC. | $13.75 | 2019 | |
| Assertio Therapeutics, INC. | $13.22 | 2020 | |
| Djo, LLC | $12.03 | 2019 | |
| Alfasigma USA, INC. | $11.27 | 2021 | |
| Glenmark Therapeutics INC. | $5.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chansina Um listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.